Clinical Trials in Massachusetts

Showing 1841-1860 of 15,316 trials

Effect of Cash Benefits on Health Care Spending

NCT07381049

During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate monthly cash benefits to its residents. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on health care spending.

Health Care CostsHealth Care Utilization

Harvard Medical School (HMS and HSDM)3,615 participantsStarted Jul 2020

Boston, Massachusetts, United States • Cambridge, Massachusetts, United States • Ann Arbor, Michigan, United States

RECRUITINGNA26 miles

Well-being in IBS: Strengths and Happiness (WISH) 2.0

NCT06866106

The purpose of this study is to examine the feasibility, acceptability, preliminary effects, and candidate gut-brain mechanisms of an optimized positive psychology (PP) intervention for patients with irritable bowel syndrome (IBS), entitled "WISH," compared to an educational control intervention.

Irritable Bowel Syndrome

Massachusetts General Hospital50 participantsStarted Oct 2025

Boston, Massachusetts, United States

Effect of Cash Benefits on Health Care Spending

Well-being in IBS: Strengths and Happiness (WISH) 2.0

Find Trials by Condition in Massachusetts

I-DECIDE After Bronchiolitis Hospitalization

Micra AV Transcatheter Pacing System Post-Approval Registry

Rate of Progression in USH2A-related Retinal Degeneration

Resilient Families Feasibility Trial

A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Team Science (The Liver Health Study)

Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)